Hikal Q2 Results
- BSE: 524735
- NSE: HIKAL
- ISIN: INE475B01022
- Sector: Biotechnology & Drugs
BSE
369
-4.65 (-1.24%)
-4.65 (-1.24%)Volume13.11 K
Updated: Fri 17 Jan, 2025 | 15:29:55
NSE
369.2-4.35 (-1.16%)
-4.35 (-1.16%)Volume1.03 L
Updated: Fri 17 Jan, 2025 | 15:44:29
Technical Trends
Long TermConsiders price movement over the last 6 months
Not Available
Short TermConsiders price movement over the last 1-2 weeks
Not Available
- Bearish
- Moderately Bearish
- Neutral
- Moderately Bullish
- Bullish
Insight: Trends unavailable at the moment.
Q2 Results Highlights
- Total Income₹452.90 Cr.(4.14%)
- Operating Profit₹43.20 Cr.(49.22%)
- Profit After Tax₹18.30 Cr.(45.58%)
- Operating Margin9.54%(43.29%)
Note: Comparison is on YoY basis
Quarterly - Hikal Q2 Results
*All figures in crores except per share values
| Fiscal Period | Sep 24 | Jun 24 | QoQ Comp | Sep 23 | YoY Comp |
|---|---|---|---|---|---|
| Total Revenue | 452.90 | 406.80 | 11.33% | 434.88 | 4.14% |
| Selling/ General/ Admin Expenses Total | 62.10 | 57.10 | 8.76% | 61.81 | 0.47% |
| Depreciation/ Amortization | 31.70 | 31.80 | -0.31% | 28.57 | 10.96% |
| Other Operating Expenses Total | 114.00 | 99.40 | 14.69% | 102.43 | 11.30% |
| Total Operating Expense | 409.70 | 380.60 | 7.65% | 405.93 | 0.93% |
| Operating Income | 43.20 | 26.20 | 64.89% | 28.95 | 49.22% |
| Net Income Before Taxes | 24.80 | 6.90 | 259.42% | 16.86 | 47.09% |
| Net Income | 18.30 | 5.10 | 258.82% | 12.57 | 45.58% |
| Diluted Normalized EPS | 1.48 | 0.41 | 260.98% | 1.02 | 45.10% |